TCTAP A-074 Development of a Fenestrated Window Shape Aortic Arch Stent Graft with a Preloaded Catheter for Protecting Branch Arteries: An Experimental Study in Swine  by Lee, Han Cheol et al.
S38 J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y , V O L . 6 5 , N O . 1 7 , S U P P L S , 2 0 1 5TCTAP A-072
Availability of Modiﬁed Dialysis for Dialysis Patient After Using Contrast
Dye in Cardiac Catheterization
Kenta Murakami,1 Ryosuke Kametani,1 Akimitsu Tanaka1
1Nagoya Tokushukai General Hospital, Japan
BACKGROUND In hemodialyzed patient, we can often seethe
complication (ex. Hypotension, bad feeling) in hemodialysis (HD) af-
ter cardiac catheterization. So we made modiﬁcation for HD after the
ﬁrst time cardiac catheterization. Content of the modify HD are that
the blood osmolality was changed slowly.
METHODS The candidate was our consecutive HD patients (218 pa-
tients, 157 male, 67.1  9.8 y.o.) who performed cardiac catheteriza-
tion from February 2009 to August 2014. From February 2009 to
December 2012 we performed usual HD after cardiac catheterization
(HD group: 157 patients). From January 2013 to August 2014 we per-
formed modiﬁed HD after that (mHD group: 61 patients). Content of
modify were that we decreased dialysis ﬂow rate (300 ml/min) in
anterior half of HD; in posterior half we performed ordinary HD. The
deﬁnition of the complication are discontinuity of HD from hypo-
tension or/and bad feeling, Unattainable of defecated water and
requisition of infusion solution.
RESULTS Developed the complication of HD group was 59 patients
(37.6 %), mHD group was 7 patients (11.3 %). It was signiﬁcant dif-
ference between the groups (p¼0.00013).
CONCLUSION Our Modifying, the blood osmolality was changed
slowly, of HD after the ﬁrst time cardiac catheterization was useful for
reducing the rate complication.
HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
(TCTAP A-073)
TCTAP A-073
Alcohol Septal Ablation in Hypertrophic Cardiomyopathy: A Prospective
Study
Praskas Chandra Mandal,1 Debabrata Bera1
1Apollo Gleneagles Hospital, India
BACKGROUND Hypertrophic cardiomyopathy (HCM) is the most
common genetic cardiovascular disease caused by multiple muta-
tions of cardiac sarcomeres. Resting and provocable left ventricular
outﬂow tract (LVOT) gradient is a strong determinant of morbidity
and mortality in patients with hypertrophic cardiomyopathy. He-
modynamic and electrical complications are more common in pa-
tients with LVOT obstruction in compared to patients of HCM
without LVOT obstruction. Relief of LVOT obstruction improves both
symptoms and long term survival. Surgical myectomy is now the
preferred method of relieving LVOT obstruction. Alcohol septal
ablation in HCM is generally reserved for sypmtomatic patients who
are not suitable candidates for surgical myectomy. In practical sce-
nario another large proportion of patients refuse for surgical mode of
therapy. We conducted a prospective study in a tertiary care hospital
in Eastern India over last 10 years including these two groups of
patients with a goal to study immediate and long term results of
alcohol septal ablation.
METHODS We enrolled 51 patients of obstructive HCM (peak LVOT
gradient 50 mm of Hg) over 5 years (Nov 2004 to Oct 2009) who
were persistently symptomatic on medical management. Ten pa-
tients were not suitable candidates for surgery. Among the rest ofthe subjects, 26 patients refused surgical treatment. We included
only the obstructive variety (HOCM) of patients who were class III to
class IV symptomatic despite optimal medical management with
beta-blocker, calcium-channel blocker and disopyramide. Patients
with isolated mid-cavity obstruction were excluded from the study.
Alcohol septal ablation was performed on 36 patients who were not
suitable candidates for surgery or not willing to undergo surgery.
The procedure could not be completed in one patient due to he-
modynamically unstable incessant ventricular tachycardia. Subse-
quently 35 patients were followed up for next 5 years both clinically
and with echocardiography.
RESULTS The mean age at intervention was 3210 years. The peak
dynamic LVOT gradient pre-operatively was 7320 mm Hg. Alcohol
septal ablation was performed successfully in all 35 patients with
immediate LVOT gradient reduction. The peak LVOT gradient post-
operatively was 137 mm of Hg. Three patients developed complete
heart block during the procedure, among which 2 patients reverted
back spontaneously to sinus rhythm within 72 hours. One patient did
not revert back and permanent pacemaker was implanted. Over next
5-8 years follow up 4 patients died (2 patients with refractory heart
failure, 2 patients with sudden cardiac death). Three patients devel-
oped atrial ﬁbrillation over follow up. Rest of the patients is doing
well symptomatically and echocardiography showed no recurrence of
signiﬁcant LVOT obstruction.
CONCLUSION HCM is a complex genetic disorder with several long
term complications especially in the obstructive variety. Though it is
said to reserve alcohol septal ablation (Class IIa) only for those who
are not suitable candidates for surgical mectomy, a large group of
symptomatic patients who refuse for surgical option can also be
treated successfully with alcohol septal ablation. The immediate and
long-term outcome is good.
INNOVATIVE DEVICES AND FUTURISTIC THERAPIES
(TCTAP A-074 TO TCTAP A-075)
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Development of a Fenestrated Window Shape Aortic Arch Stent Graft with
a Preloaded Catheter for Protecting Branch Arteries: An Experimental
Study in Swine
Han Cheol Lee,1 In Sub Han,1 Hye Won Lee,1 Jun-Hyok Oh,1
Kwang Soo Cha,1 Taeg Jong Hong1
1Pusan National University Hospital, Korea (Republic of)
BACKGROUND Thoracic endovascular aortic repair (TEVAR) shows
limitations in cases where the aortic pathology involves the aortic
arch and only a short proximal landing zone is thereby available for
the stent graft. In our previous study, we developed a round shape
fenestrated aortic arch stent graft (FASG) with a preloaded catheter
for protecting branch arteries. But, FASG with round shape fenes-
tration is not available in case of emergency as aortic rupture,
complicated aortic dissection because FASG with round shape
fenestration is manufactured individually. In this study, we devel-
oped a window shape FASC with a preloaded catheter for protecting
branch arteries and performed a preclinical study with this device
in swine.
METHODS The FASG is a self-expandable nitinol-PTEF stent graft
with window shape fenestration and preloading catheter that is
designed to access right carotid artery safely. We design a window
shaped fenestration and preloading catheter placed inside the stent
graft to save blood ﬂow to the carotid, left subclavian arteries. After
window shape FASG is partially deployed, 0.35 inch guidewire is
placed into the right carotid artery and then stent graft is fully
deployed. Following separate stent graft for right carotid artery is
deployed. The sizes of fenestrated window were 30mm in width,
15mm in length and 40mm in width, 15mm in length.
Six FASGs with window shaped fenestration and a side branch
stent graft were advanced through the iliac artery in 6 swines
weighing 70–80 kg. The presence of endoleaks and the patency and
deformity of the grafts were examined with digital subtraction
angiography (DSA) at 4 weeks postoperatively. A postmortem ex-
amination was performed at 8 weeks to evaluate the gross
morphology, patency, and deformity of the FASGs with window
shaped fenestration.
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fenestration was 23.0  6.0 minutes. Meanwhile, the mean time for the
selection of the right carotid artery was 3.6 0.9minutes. There was no
major adverse event in the 6 pigs. Six pigs survived the 8-weeks
observational period. For FASGs with window shaped fenestration, no
endoleaks, no disconnection of the stent grafts, and no occlusion of the
stent grafts for the carotid arteries were observed in the DSA at 4weeks.
Moreover, no disconnection or tearing of the stent grafts, no fractures in
the stent grafts, and no occlusion of the stent graft for carotid arteries
were found in the postmortem gross ﬁndings.
CONCLUSION The window shape FASG with the preloaded catheter
developed for emergencywas found to be safe and convenient to use in this
preclinical studywith swine. Readymadewindow shape FASGswhich have
several sized fenestrated window can be applied in case of emergency.TCTAP A-075
High-Flow Continuous Hemodiaﬁltration (HF-CHDF) During CAG and
PCI/PPI for Prevention of Contrast-Induced Nephropathy in Patients
with Advanced Chronic Kidney Disease: A Pilot Study
Naofumi Oyamada,1 Ichiro Hamanaka,1 Hiroaki Fujie,1 Kinzo Ueda1
1Rakuwakai Marutamachi Hospital, Japan
BACKGROUND Although it is well known that the chronic kidney
disease (CKD) is a key factor for CIN, the effective therapy for the
prevention of CIN especially in advanced CKD-Patients has not been
established so far. Recently, it was reported that continuous hemo-
ﬁltration (CHF) could prevent CIN and reduce in-hospital mortality in
advanced CKD-patients via both ﬁltrating contrast and administration
of alkaline agents. However, this method requires a long duration-
time (18 to 30 hours) because of its low removal efﬁciency. Applying
this principle, we established a novel continuous hemodiaﬁltration
(CHDF) technique to get more effective blood clariﬁcation which
promotes replacement and dialysate ﬂow up to 5 times compared to
standard CHDF. By using this method we demonstrated that the
required time for 99 % removal of contrast could be shorten to one
sixth (about 4.5 hours) in our vitro experiment and named this pro-
cedure as High-ﬂow CHDF (HF-CHDF). In this report, we performed
HF-CHDF in clinical application for advanced CKD-Patients required
intervention.
METHODS We retrospectively analyzed the incidence of CIN in
consecutive 43 advanced CKD patients (8 in stage3b, 33 in stage4, and
2 in stage5) from Jan. 2009 to Dec. 2013. In addition of 0.9 % saline
hydration, HF-CHDF was performed from just before the procedure
until 2.5 hours after intervention in all patients. We deﬁned CIN as
sCre increase over 25 % from the baseline value at the point of 1 month
after intervention.
RESULTS At baseline, mean serum creatinine (sCre) was 2.31  0.62
mg/dl, and mean eGFR was 24.0  6.5 ml/min/1.73m2. And, sCre was
2.29  0.79 mg/dl, eGFR 25.6  9.6 ml/min/1.73m2 at 1 month after
procedure. The incidence of CIN was 4.6% (2 in 43), which was
remarkably lower than previous reports (the incidence of CIN by
hydration only was 15-20%, by alkaline agents was 10-15%). Rate of
occurrence requiring permanent HD due to CIN within 1year was
2.3%.CONCLUSION HF-CHDF method during and after PCI and PPI proce-
dure which we have established could be new standard for preventing
CIN in advanced CKD-patients required intervention.
Following this pilot study, multi-center trial is now ongoing to
construct further evidence in Japan.INVASIVE CORONARY IMAGING: IVUS, OCT,
SPECTROSCOPY, AND OTHER
(TCTAP A-076 TO TCTAP A-083)
TCTAP A-076
Pattern of In-Stent Restenosis in Saphenous Coronary Vein Grafts – Insight
from Optical Coherence Tomography (OCTOPUS Registry)
Tomasz Roleder,1 Wojciech Wanha,1 Wieslaw Cybulski,1
Grzegorz Smolka,1 Mariusz Skowerski,1 Andrzej Ochala,1
Zbigniew Gasior,1 Michal Tendera,1 Wojciech Wojakowski1
1Medical University of Silesia, Poland
BACKGROUND Approximately 30% of stents implanted into saphe-
nous vein grafts (SVG) fail at 3-years follow-up. Although the pa-
thology of in stent restenosis (ISR) in SVG was presented by autopsy
study, there are just few reports using invasive imaging.
METHODS The report presents optical coherence imaging (OCT) im-
aging of ISR in SVG from 8 cases [in total 168 mm of ISR morphology]
enrolled into OCTOPUS Registry. The mean time from implantation
was 3123 months.
RESULTS The report presents optical coherence imaging (OCT) im-
aging of ISR in SVG from 8 cases [in total 168 mm of ISR morphology]
enrolled into OCTOPUS Registry. The mean time from implantation
was 3123 months.
Figure. The summary graph of in-stent neointima composition of ISR in SVG
The ﬁgure represents neoinitma composition in every 1mm in restenosis BMS and DES implanted into
the SVG. A one circle and a one box indicate a 1mm of BMS and DES respectively
CONCLUSION Patterns of in-stent neointima of SVG ISR were shown:
ﬁbrotic, lipid, heterogeneous, and calciﬁed. Heterogeneous pattern
seems to develop earlier in DES vs. BMS.
